Literature DB >> 23712038

Enhanced CRAd activity using enhancer motifs driven by a nucleosome positioning sequence.

Soraya Bravo1, Felipe Núñez, Fernando Cruzat, Eduardo G Cafferata, Giancarlo V De Ferrari, Martín Montecino, Osvaldo L Podhajcer.   

Abstract

Cancer development involves changes driven by the epigenetic machinery, including nucleosome positioning. Recently, the concept that adenoviral replication may be driven by tumor specific promoters (TSPs) gained support, and several conditionally replicative adenoviruses (CRAd) exhibited therapeutic efficacy in clinical trials. Here, we show for the first time that placing a nucleosome positioning sequence (NPS) upstream of a TSP combined with Wnt-responsive motifs (pART enhancer) enhanced the TSP transcriptional activity and increased the lytic activity of a CRAd. pART enhanced the transcriptional activity of the gastrointestinal cancer (GIC)-specific REG1A promoter (REG1A-pr); moreover, pART also increased the in vitro lytic activity of a CRAd whose replication was driven by REG1A-Pr. The pART enhancer effect in vitro and in vivo was strictly dependent on the presence of the NPS. Indeed, deletion of the NPS was strongly deleterious for the in vivo antitumor efficacy of the CRAd on orthotopically established pancreatic xenografts. pART also enhanced the specific activity of other heterologous promoters; moreover, the NPS was also able to enhance the responsiveness of hypoxia- and NFκB-response elements. We conclude that NPS could be useful for gene therapy approaches in cancer as well as other diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23712038      PMCID: PMC3702098          DOI: 10.1038/mt.2013.93

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  45 in total

1.  A novel conditionally replicating "armed" adenovirus selectively targeting gastrointestinal tumors with aberrant wnt signaling.

Authors:  Xinjian Liu; Qijun Qian; Ping Xu; Frank Wolf; Jufeng Zhang; Dabing Zhang; Chuanyuan Li; Qian Huang
Journal:  Hum Gene Ther       Date:  2011-02-16       Impact factor: 5.695

2.  Targeting of autonomous parvoviruses to colon cancer by insertion of Tcf sites in the P4 promoter.

Authors:  M Malerba; D Nikolova; J Cornelis; R Iggo
Journal:  Cancer Gene Ther       Date:  2006-03       Impact factor: 5.987

3.  Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumors.

Authors:  Cleo Y F Lee; Luke X X Bu; Arrigo DeBenedetti; B Jill Williams; Paul S Rennie; William W G Jia
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

Review 4.  Gene therapy developments for pancreatic cancer.

Authors:  Madhumita Bhattacharyya; Nick R Lemoine
Journal:  Best Pract Res Clin Gastroenterol       Date:  2006-04       Impact factor: 3.043

Review 5.  COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention.

Authors:  Mary-Clare Cathcart; Kenneth J O'Byrne; John V Reynolds; Jacintha O'Sullivan; Graham P Pidgeon
Journal:  Biochim Biophys Acta       Date:  2011-10-01

6.  Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

Authors:  V N Krasnykh; G V Mikheeva; J T Douglas; D T Curiel
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

7.  Immunohistochemical analysis of REG Iα expression in ulcerative colitis-associated neoplastic lesions.

Authors:  Hiroyuki Tanaka; Hirokazu Fukui; Shigehiko Fujii; Akira Sekikawa; Hidetsugu Yamagishi; Kazuhito Ichikawa; Shigeki Tomita; Johji Imura; Yoshikazu Yasuda; Tsutomu Chiba; Takahiro Fujimori
Journal:  Digestion       Date:  2011-01-21       Impact factor: 3.216

Review 8.  Cyclooxygenases 1 and 2.

Authors:  J R Vane; Y S Bakhle; R M Botting
Journal:  Annu Rev Pharmacol Toxicol       Date:  1998       Impact factor: 13.820

9.  Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma.

Authors:  V Korinek; N Barker; P J Morin; D van Wichen; R de Weger; K W Kinzler; B Vogelstein; H Clevers
Journal:  Science       Date:  1997-03-21       Impact factor: 47.728

10.  The pathobiological features of gastrointestinal cancers (Review).

Authors:  Xue Yang; Yasuo Takano; Hua-Chuan Zheng
Journal:  Oncol Lett       Date:  2012-03-01       Impact factor: 2.967

View more
  2 in total

1.  Hepatocellular carcinoma-targeting oncolytic adenovirus overcomes hypoxic tumor microenvironment and effectively disperses through both central and peripheral tumor regions.

Authors:  A-Rum Yoon; JinWoo Hong; Minjung Kim; Chae-Ok Yun
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

2.  A NOTCH-sensitive uPAR-regulated oncolytic adenovirus effectively suppresses pancreatic tumor growth and triggers synergistic anticancer effects with gemcitabine and nab-paclitaxel.

Authors:  Ana Mato-Berciano; Giulia Raimondi; Maria Victoria Maliandi; Ramon Alemany; Lluis Montoliu; Cristina Fillat
Journal:  Oncotarget       Date:  2017-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.